Is There A Pickup Coming For Biotech IPOs?

Download Audio

It’s been a relatively slow year for the U.S. biotech sector. So far, only 16 companies nationwide have gone public since January.

That’s about half as many as during the boom years between 2013 and 2015.

But the last couple of weeks have seen four IPOs, including two here in Massachusetts, for the firms Mersana and Aileron. Both are focused on cancer drugs.

For a look at the dry spell, and what might be driving the possible shift underway, we spoke to Luke Timmerman, founder and editor of the biotech industry newsletter the Timmerman Report.

This segment aired on July 10, 2017.

Headshot of Bob Oakes

Bob Oakes Senior Correspondent
Bob Oakes was a senior correspondent in the WBUR newsroom, a role he took on in 2021 after nearly three decades hosting WBUR's Morning Edition.



More from WBUR

Listen Live